Industry Webinars


HeartMate 3 LVAD™ Clinical Data Presentations - ISHLT 2020 Annual Meeting

This video is a collection of mini-oral presentations by leading thought leaders discussing their research in patients who received the HeartMate 3 LVAD. These studies were highlighted at The International Society of Heart and Lung Transplantation (ISHLT) Annual Meeting in 2020. Abbott has a deep commitment to well-designed clinical research and outcomes, and these presentations will inform the future of patient care.

Dr. Robert L. Kormos, Abbott | Facilitator
Dr. Omar Saeed, Montefiore-Einstein Medical Center | Effect of Aspirin Dose on Hemocompatibility Related Outcomes with a Magnetically Levitated Left Ventricular Assist Device: An Analysis from the MOMENTUM 3 Study
Dr. Manreet K. Kanwar, Allegheny General Hospital | Impact of Left Ventricular Assist Device Implantation on Mitral Regurgitation: An Analysis from the MOMENTUM 3 Trial
Dr. Jonathan W. Haft, University of Michigan | The Impact of Heartmate 3 Speed on Outcomes in the Momentum 3 Clinical Trial
Dr. Jennifer Cowger, Henry Ford Hospital | Variability in Blood Pressure Assessment in Patients Supported with the HeartMate 3
Dr. Ivan Netuka, Institute of Clinical and Experimental Medicine | First Long-Term 5-years Experience with the HeartMate 3 LVAS in Multicentric Clinical Trial


HeartCare Multi-Modality Testing for Heart Transplant Patients


Dr. Kiran Khush, Stanford University | Donor-Derived Cell-Free DNA and Gene Expression Profiling: A Combined Approach to Heart Transplantation Surveillance
Dr. Eugene DePasquale, University of Southern California | Review of Patient Case Studies and the Role of HeartCare


VAD Therapy Trends: Why Meaningful Data Matters

Hear key opinion leaders from around the world share their experiences in mechanical circulatory support. Watch this lively discussion, as the presenters explore data and trends in surgical approach, right heart failure, and patient management to achieve excellent outcomes for patients implanted with the HVAD™ System.

Dr. Mark Slaughter, Jewish Hospital and St. Mary's Healthcare System

Dr. Anson Cheung, University of British Columbia and St. Paul's Hospital
Dr. Erika Feller, University of Maryland Medical Center
Prof. Dr. med. Evgenij V. Potapov, Deutsches Herzzentrum Berlin
Dr. Christopher T. Salerno, St. Vincent Hospital Indianapolis
Dr. Stephan Schueler, Freeman Hospital


Advanced Heart Preservation for 2021: Paragonix SherpaPak CTS

The Paragonix Team assembled a panel of industry-leading experts to host this seminal discussion on current and future preservation techniques for heart transplantation in both adults and children. Relying on over a century of transplant experience, the panel investigates the importance of well-controlled preservation systems for organ transportation in improved patient outcomes.

Dr. Yasuhiro Shudo, Stanford University | Pioneering Advanced Preservation on the West Coast
Dr. Rajamiyer Venkateswaran, Wythenshawe Hospital | ISHLT Consensus Statement and UK National SherpaPak Program
Dr. Ulrich Stock, Harefield Hospital | Introduction of Advanced Hypothermic Preservation
Dr. Jeffrey Jacobs, University of Florida